Truist Securities Maintains Buy on Eli Lilly and Co, Raises Price Target to $892
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Srikripa Devarakonda has maintained a Buy rating on Eli Lilly and Co (LLY) and increased the price target from $850 to $892.
May 01, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on Eli Lilly and Co, raising the price target from $850 to $892.
The increase in price target by Truist Securities reflects a positive outlook on Eli Lilly's stock, suggesting potential upside. This analyst endorsement could lead to increased investor confidence and a short-term rise in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100